[Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland?].
Primary prevention of cardiovascular disease by physicians is achieved by management of individual risk factors. The eligibility for treatment with statins is based on both an estimate of the risk of developing cardiovascular disease and the LDL-cholesterol. Three risk scores are commonly used: the PROCAM score, the Framingham score, and the European score. In Switzerland, the Swiss Group Lipids and Atherosclerosis (GSLA) recommends to use the PROCAM score with an adjustment of the level of risk for Switzerland. A survey also showed that PROCAM is the most used in Switzerland. In this article, the differences of these scores and their practical applications regarding the prescription of statins in primary prevention are discussed. The consequences and potential benefits of applying these scores in Switzerland are also discussed.
Nanchen
David
D
PMU, Lausanne. david.nanchen@chuv.ch
Chiolero
Arnaud
A
Marques-Vidal
Pedro-Manuel
PM
Cornuz
Jacques
J
Waeber
Gérard
G
Vollenweider
Peter
P
Rodondi
Nicolas
N
D000328:Adult; D000367:Age Factors; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control*; D008078:Cholesterol, LDL / Q000097:blood; D011307:Drug Prescriptions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention; D018570:Risk Assessment; D012307:Risk Factors; D012737:Sex Factors; D013557:Switzerland; D013997:Time Factors
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL